New Immune Checkpoint Inhibitor Approved for Bladder Cancer
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
Category: AACR
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
Members of the AACR Project GENIE consortium presented their first analyses of the data during the Pan-Cancer Genomic Analysis...
May is National Cancer Research Month, during which the American Association for Cancer Research partners with advocacy groups, cancer...
On Thursday, the U.S. Food and Drug Administration (FDA) expanded the use of the antiangiogenic therapeutic regorafenib (Stivarga) to...
The American Association for Cancer Research (AACR) Annual Meeting 2017 brought some of the world’s greatest scientific minds to...
Last month, U.S. Rep. Donald Payne Jr. (D-New Jersey), led a roundtable discussion at University Hospital in Newark, New...
Two studies presented at the AACR Annual Meeting 2017 showed that tumors that have mutations in the proteins isocitrate...
On March 23, the U.S. Food and Drug Administration announced the first-ever approval of a treatment for patients with...
Finding a way to therapeutically target the so-called “undruggable” cancer proteins has long been a holy grail of researchers...
The Affordable Care Act, which was enacted in 2010 and recently survived an effort to dismantle it, was the...